Cited 8 time in
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jung, Da Hyun | - |
| dc.contributor.author | Youn, Young Hoon | - |
| dc.contributor.author | Jung, Hye-Kyung | - |
| dc.contributor.author | Kim, Seung Young | - |
| dc.contributor.author | Huh, Cheal Wung | - |
| dc.contributor.author | Shin, Cheol Min | - |
| dc.contributor.author | Oh, Jung-Hwan | - |
| dc.contributor.author | Huh, Kyu Chan | - |
| dc.contributor.author | Park, Moo In | - |
| dc.contributor.author | Choi, Suck Chei | - |
| dc.contributor.author | Kim, Ki Bae | - |
| dc.contributor.author | Park, Seon-Young | - |
| dc.contributor.author | Kwon, Joong Goo | - |
| dc.contributor.author | Cho, Yu Kyung | - |
| dc.contributor.author | Park, Jung Ho | - |
| dc.contributor.author | Shin, Jeong Eun | - |
| dc.contributor.author | Gong, Eun Jeong | - |
| dc.contributor.author | Kim, Jae Hak | - |
| dc.contributor.author | Hong, Su Jin | - |
| dc.contributor.author | Kim, Hyun Jin | - |
| dc.contributor.author | Jee, Sam Ryong | - |
| dc.contributor.author | Lee, Ju Yup | - |
| dc.contributor.author | Jung, Kee Wook | - |
| dc.contributor.author | Kim, Hee Man | - |
| dc.contributor.author | Lee, Kwang Jae | - |
| dc.date.accessioned | 2023-11-15T08:42:46Z | - |
| dc.date.available | 2023-11-15T08:42:46Z | - |
| dc.date.issued | 2023-10 | - |
| dc.identifier.issn | 2093-0879 | - |
| dc.identifier.issn | 2093-0887 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/68514 | - |
| dc.description.abstract | Background/Aims It remains unclear which maintenance treatment modality is most appropriate for mild gastroesophageal reflux disease (GERD). We aimed to compare on-demand treatment with continuous treatment using a proton pump inhibitor (PPI) in the maintenance treatment for patients with non-erosive GERD or mild erosive esophagitis. Methods Patients whose GERD symptoms improved after 4 weeks of standard dose PPI treatment were prospectively enrolled at 25 hospitals. Subsequently, the enrolled patients were randomly assigned to either an on-demand or a continuous maintenance treatment group, and followed in an 8-week interval for up to 24 weeks. Results A total of 304 patients were randomized to maintenance treatment (continuous, n = 151 vs on-demand, n = 153). The primary outcome, the overall proportion of unwillingness to continue the assigned maintenance treatment modality, failed to confirm the non-inferiority of on-demand treatment (45.9%) compared to continuous treatment (36.1%). Compared with the on-demand group, the GERD symptom and health-related quality of life scores significantly more improved and the overall satisfaction score was significantly higher in the continuous treatment group, particularly at week 8 and week 16 of maintenance treatment. Work impairment scores were not different in the 2 groups, but the prescription cost was less in the on-demand group. Serum gastrin levels significantly elevated in the continuous treatment group, but not in the on-demand group. Conclusions Continuous treatment seems to be more appropriate for the initial maintenance treatment of non-erosive GERD or mild erosive esophagitis than on-demand treatment. Stepping down to on-demand treatment needs to be considered after a sufficient period of continuous treatment. © 2023 The Korean Society of Neurogastroenterology and Motility. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society of Neurogastroenterology and Motility | - |
| dc.title | On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5056/jnm23130 | - |
| dc.identifier.scopusid | 2-s2.0-85174961627 | - |
| dc.identifier.wosid | 001091833800001 | - |
| dc.identifier.bibliographicCitation | Journal of Neurogastroenterology and Motility, v.29, no.4, pp 460 - 469 | - |
| dc.citation.title | Journal of Neurogastroenterology and Motility | - |
| dc.citation.volume | 29 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 460 | - |
| dc.citation.endPage | 469 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART003013599 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
| dc.subject.keywordPlus | ACTIVITY IMPAIRMENT QUESTIONNAIRE | - |
| dc.subject.keywordPlus | WORK PRODUCTIVITY | - |
| dc.subject.keywordPlus | OMEPRAZOLE | - |
| dc.subject.keywordPlus | MANAGEMENT | - |
| dc.subject.keywordPlus | ESOMEPRAZOLE | - |
| dc.subject.keywordPlus | ESOPHAGITIS | - |
| dc.subject.keywordPlus | EFFICACY | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | IMPACT | - |
| dc.subject.keywordPlus | MG | - |
| dc.subject.keywordAuthor | Gastroesophageal reflux | - |
| dc.subject.keywordAuthor | Maintenance | - |
| dc.subject.keywordAuthor | Proton pump inhibitors | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
